Supreme Court of the United States
Skip Navigation LinksHome > Search Results



Docket for 23-768
RSS Feed Print Notify Me
Search documents in this case:
No. 23-768
Title:Vanda Pharmaceuticals Inc., Petitioner
v.
Teva Pharmaceuticals USA, Inc., et al.
Docketed:January 17, 2024
Linked with 23A344
Lower Ct:United States Court of Appeals for the Federal Circuit
   Case Numbers:(2023-1247)
   Decision Date:May 10, 2023
   Rehearing Denied:August 16, 2023
  Discretionary Court Decision Date:

DateProceedings and Orders
Oct 13 2023Application (23A344) to extend the time to file a petition for a writ of certiorari from November 14, 2023 to January 12, 2024, submitted to The Chief Justice.
Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsProof of Service
Oct 18 2023Application (23A344) granted by The Chief Justice extending the time to file until January 12, 2024.
Jan 12 2024Petition for a writ of certiorari filed. (Response due February 16, 2024)
PetitionAppendixCertificate of Word CountProof of Service
Jan 31 2024Waiver of right of respondent Teva Pharmaceuticals USA, Inc. to respond filed.
Main Document
Jan 31 2024Waiver of right of respondents Apotex Inc. and Apotex Corp. to respond filed.
Main Document
Feb 07 2024DISTRIBUTED for Conference of 2/23/2024.
Feb 07 2024Brief amici curiae of Salix Pharmaceuticals, Inc. and Ocular Therapeutix, Inc. filed. (Distributed)
Main DocumentCertificate of Word CountProof of Service
Feb 14 2024Brief amici curiae of American Council of the Blind, Blinded Veterans Association, and PRISMS filed.
Main DocumentProof of ServiceCertificate of Word Count
Feb 15 2024Response Requested. (Due March 18, 2024)
Feb 16 2024Brief amici curiae of Professor Christopher M. Turoski and The National Association of Patent Practitioners filed.
Main DocumentProof of ServiceCertificate of Word Count
Mar 18 2024Brief of respondent Teva Pharmaceuticals USA, Inc. in opposition filed.
Main DocumentProof of ServiceCertificate of Word Count
Apr 02 2024Reply of petitioner Vanda Pharmaceuticals Inc. filed. (Distributed)
Main DocumentCertificate of Word CountProof of Service
Apr 03 2024DISTRIBUTED for Conference of 4/19/2024.
Apr 22 2024Petition DENIED.

NAMEADDRESSPHONE
Attorneys for Petitioner
Paul Whitfield Hughes
    Counsel of Record		McDermott Will & Emery
500 North Capitol Street, NW
Washington, DC 20001

PHUGHES@MWE.COM		(202) 756-8981
Party name: Vanda Pharmaceuticals Inc.
Attorneys for Respondents
Aaron Scott Lukas
    Counsel of Record		Cozen O'Connor
1200 Nineteenth Street, N.W.
Washington, DC 20036

alukas@cozen.com		202-912-4823
Party name: Apotex Inc. and Apotex Corp.
John Christopher Rozendaal
    Counsel of Record		Sterne, Kessler, Goldstein & Fox P.L.L.C.
1101 K Street NW, 10th Floor
Washington, DC 20005

jcrozendaal@sternekessler.com		2027728747
Party name: Teva Pharmaceuticals USA, Inc.
Other
Mark Simon Davies
    Counsel of Record		Orrick, Herrington & Sutcliffe LLP
Columbia Center
1152 15th Street NW
Washington, DC 20005

mark.davies@orrick.com		202-339-8631
Party name: American Council of the Blind, Blinded Veterans Association, and PRISMS
Justin James Hasford
    Counsel of Record		Finnegan Henderson Farabow Garrett and Dunner, LLP
901 New York Avenue, NW
Washington, DC 20001

justin.hasford@finnegan.com		202-408-4175
Party name: Salix Pharmaceuticals, Inc. and Ocular Therapeutix, Inc.
Ryan C. Morris
    Counsel of Record		Workman Nydegger
60 East South Temple, Suite 1000
Salt Lake City, UT 84111

rmorris@wnlaw.com		(801) 533-9800
Party name: Professor Christopher M. Turoski and The National Association of Patent Practitioners

 

Opinions
Filing & Rules
Oral Arguments
Case Documents
News Media
About
Visit
Contact Us | Site Map | Help | Fellows Program | Jobs | Links | Website Policies and Notices | Privacy Policy | USA.GOV
SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543